Concord Medical Services Holdings Limited
CCM
$5.09
-$0.16-2.99%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 53.36M | 59.39M | 65.32M | 70.51M | 76.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.36M | 59.39M | 65.32M | 70.51M | 76.06M |
| Cost of Revenue | 64.36M | 70.50M | 76.50M | 81.50M | 86.89M |
| Gross Profit | -11.00M | -11.11M | -11.19M | -10.99M | -10.82M |
| SG&A Expenses | 63.02M | 56.92M | 50.66M | 52.48M | 54.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.39M | 127.42M | 127.17M | 133.98M | 141.40M |
| Operating Income | -74.03M | -68.02M | -61.85M | -63.47M | -65.34M |
| Income Before Tax | -93.08M | -92.28M | -91.30M | -84.68M | -78.27M |
| Income Tax Expenses | -2.43M | -1.90M | -1.36M | -2.43M | -3.54M |
| Earnings from Continuing Operations | -90.65 | -90.38 | -89.93 | -82.25 | -74.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 47.81M | 42.68M | 37.46M | 35.18M | 33.00M |
| Net Income | -42.84M | -47.70M | -52.47M | -47.07M | -41.72M |
| EBIT | -74.03M | -68.02M | -61.85M | -63.47M | -65.34M |
| EBITDA | -57.43M | -51.52M | -45.25M | -46.57M | -48.08M |
| EPS Basic | -294.20 | -327.58 | -360.33 | -323.24 | -286.52 |
| Normalized Basic EPS | -0.67 | -1.71 | -2.74 | -2.74 | -2.74 |
| EPS Diluted | -294.75 | -328.12 | -360.86 | -323.77 | -287.05 |
| Normalized Diluted EPS | -0.67 | -1.71 | -2.74 | -2.74 | -2.74 |
| Average Basic Shares Outstanding | 17.47M | 17.47M | 17.47M | 17.47M | 17.47M |
| Average Diluted Shares Outstanding | 582.40K | 582.40K | 582.40K | 582.40K | 582.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |